|
US4203990A
(en)
|
1979-04-30 |
1980-05-20 |
G. D. Searle & Co. |
Anti-diarrheal 2-substituted quinuclidines
|
|
DE58906678D1
(de)
|
1988-07-28 |
1994-02-24 |
Ciba Geigy |
Kupfer- und Nickeldihalogenidkomplexe, Verfahren zu deren Herstellung und deren Verwendung.
|
|
US4922901A
(en)
|
1988-09-08 |
1990-05-08 |
R. J. Reynolds Tobacco Company |
Drug delivery articles utilizing electrical energy
|
|
EP0402056A3
(en)
|
1989-06-06 |
1991-09-04 |
Beecham Group p.l.c. |
Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
|
JPH03135978A
(ja)
|
1989-08-08 |
1991-06-10 |
Merck Sharp & Dohme Ltd |
置換ピリジン、その製法、処方並びに痴呆症における使用法
|
|
IN173570B
(enExample)
|
1989-11-23 |
1994-06-04 |
Pfizer |
|
|
DK40890D0
(da)
|
1990-02-16 |
1990-02-16 |
Ferrosan As |
Substituerede urinstofforbindelser, deres fremstilling og anvendelse
|
|
EP0492903A1
(en)
|
1990-12-21 |
1992-07-01 |
MERCK SHARP & DOHME LTD. |
Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
|
|
JP2657583B2
(ja)
|
1991-03-01 |
1997-09-24 |
ユニバーシテイ オブ フロリダ リサーチ ファンデーション インコーポレイテッド |
神経系変性疾患の治療に対するニコチン類似体の利用
|
|
US5212188A
(en)
|
1992-03-02 |
1993-05-18 |
R. J. Reynolds Tabacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5276043A
(en)
|
1992-04-10 |
1994-01-04 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5977144A
(en)
|
1992-08-31 |
1999-11-02 |
University Of Florida |
Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
|
|
AU674541B2
(en)
|
1992-08-31 |
1997-01-02 |
University Of Florida Research Foundation, Inc. |
Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system
|
|
IL107184A
(en)
|
1992-10-09 |
1997-08-14 |
Abbott Lab |
Heterocyclic ether compounds that enhance cognitive function
|
|
US5852041A
(en)
|
1993-04-07 |
1998-12-22 |
Sibia Neurosciences, Inc. |
Substituted pyridines useful as modulators of acethylcholine receptors
|
|
IL109451A0
(en)
*
|
1993-04-29 |
1994-07-31 |
Zeneca Ltd |
Heterocyclic derivatives
|
|
AU7474794A
(en)
|
1993-07-22 |
1995-02-20 |
E.I. Du Pont De Nemours And Company |
Arthropodicidal azacyclic heterocycles
|
|
US5493026A
(en)
|
1993-10-25 |
1996-02-20 |
Organix, Inc. |
Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
|
|
US5510355A
(en)
|
1994-09-06 |
1996-04-23 |
Bencherif; Merouane |
Depolarizing skeletal muscle relaxants
|
|
US5998404A
(en)
|
1994-10-24 |
1999-12-07 |
Eli Lilly And Company |
Heterocyclic compounds and their use
|
|
US5604231A
(en)
|
1995-01-06 |
1997-02-18 |
Smith; Carr J. |
Pharmaceutical compositions for prevention and treatment of ulcerative colitis
|
|
US5824692A
(en)
|
1995-01-06 |
1998-10-20 |
Lippiello; Patrick Michael |
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
|
|
US5616707A
(en)
|
1995-01-06 |
1997-04-01 |
Crooks; Peter A. |
Compounds which are useful for prevention and treatment of central nervous system disorders
|
|
US5597919A
(en)
|
1995-01-06 |
1997-01-28 |
Dull; Gary M. |
Pyrimidinyl or Pyridinyl alkenyl amine compounds
|
|
EP0809494A1
(en)
|
1995-02-17 |
1997-12-03 |
Novo Nordisk A/S |
The use of heterocyclic compounds
|
|
US5585388A
(en)
|
1995-04-07 |
1996-12-17 |
Sibia Neurosciences, Inc. |
Substituted pyridines useful as modulators of acetylcholine receptors
|
|
US5583140A
(en)
|
1995-05-17 |
1996-12-10 |
Bencherif; Merouane |
Pharmaceutical compositions for the treatment of central nervous system disorders
|
|
IL118279A
(en)
|
1995-06-07 |
2006-10-05 |
Abbott Lab |
Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
|
|
WO1997001556A1
(en)
|
1995-06-29 |
1997-01-16 |
Novo Nordisk A/S |
Novel substituted azacyclic or azabicyclic compounds
|
|
JPH11512443A
(ja)
|
1995-09-22 |
1999-10-26 |
ノボ ノルディスク アクティーゼルスカブ |
新規な置換アザ環式またはアザ二環式化合物
|
|
US5712270A
(en)
|
1995-11-06 |
1998-01-27 |
American Home Products Corporation |
2-arylamidothiazole derivatives with CNS activity
|
|
US5616716A
(en)
|
1996-01-06 |
1997-04-01 |
Dull; Gary M. |
(3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
|
|
SE9600683D0
(sv)
|
1996-02-23 |
1996-02-23 |
Astra Ab |
Azabicyclic esters of carbamic acids useful in therapy
|
|
US5663356A
(en)
|
1996-04-23 |
1997-09-02 |
Ruecroft; Graham |
Method for preparation of aryl substituted alefinic secondary amino compounds
|
|
US5726189A
(en)
|
1996-05-03 |
1998-03-10 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Method for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanes
|
|
ZA9711092B
(en)
|
1996-12-11 |
1999-07-22 |
Smithkline Beecham Corp |
Novel compounds.
|
|
US5861423A
(en)
|
1997-02-21 |
1999-01-19 |
Caldwell; William Scott |
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
|
|
US5811442A
(en)
|
1997-02-21 |
1998-09-22 |
Bencherif; Merouane |
Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
|
|
CA2289574C
(en)
|
1997-05-30 |
2007-04-24 |
Neurosearch A/S |
8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
|
|
AR013184A1
(es)
*
|
1997-07-18 |
2000-12-13 |
Astrazeneca Ab |
Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
|
|
CA2317567A1
(en)
|
1998-04-02 |
1999-10-14 |
R.J. Reynolds Tobacco Company |
Pharmaceutical compositions and methods for use
|
|
US5952339A
(en)
|
1998-04-02 |
1999-09-14 |
Bencherif; Merouane |
Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
|
|
WO1999062505A2
(en)
|
1998-06-01 |
1999-12-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for treating neurodegenerative disorders
|
|
US6310043B1
(en)
|
1998-08-07 |
2001-10-30 |
Governors Of The University Of Alberta |
Treatment of bacterial infections
|
|
GB9821503D0
(en)
|
1998-10-02 |
1998-11-25 |
Novartis Ag |
Organic compounds
|
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
US6734215B2
(en)
|
1998-12-16 |
2004-05-11 |
University Of South Florida |
Exo-S-mecamylamine formulation and use in treatment
|
|
SE9900100D0
(sv)
*
|
1999-01-15 |
1999-01-15 |
Astra Ab |
New compounds
|
|
FR2791678B1
(fr)
|
1999-03-30 |
2001-05-04 |
Synthelabo |
Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
|
|
SE9904176D0
(sv)
*
|
1999-11-18 |
1999-11-18 |
Astra Ab |
New use
|
|
SE0000540D0
(sv)
*
|
2000-02-18 |
2000-02-18 |
Astrazeneca Ab |
New compounds
|
|
GB0010955D0
(en)
|
2000-05-05 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
|
AU6610001A
(en)
|
2000-06-27 |
2002-01-08 |
S A L V A T Lab Sa |
Carbamates derived from arylalkylamines
|
|
EP1381603A2
(en)
|
2000-08-18 |
2004-01-21 |
PHARMACIA & UPJOHN COMPANY |
Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
|
|
US6486172B2
(en)
|
2000-08-18 |
2002-11-26 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted aryl compounds for treatment of disease
|
|
WO2002016356A2
(en)
|
2000-08-18 |
2002-02-28 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
|
|
AU2001284646A1
(en)
*
|
2000-08-21 |
2002-03-04 |
Pharmacia And Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
|
US6500840B2
(en)
*
|
2000-08-21 |
2002-12-31 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
|
EP1311505A2
(en)
|
2000-08-21 |
2003-05-21 |
PHARMACIA & UPJOHN COMPANY |
Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
|
|
HUP0303529A3
(en)
|
2000-12-22 |
2008-03-28 |
Almirall Ag |
New quinuclidine carbamate derivatives, process for their preparation and pharmaceutical compositions containing them and their use
|
|
US20020086871A1
(en)
*
|
2000-12-29 |
2002-07-04 |
O'neill Brian Thomas |
Pharmaceutical composition for the treatment of CNS and other disorders
|
|
KR20040003021A
(ko)
|
2001-06-01 |
2004-01-07 |
아스트라제네카 아베 |
치료에 유용한 니코틴성 아세틸콜린 수용체에 대한 신규리간드
|
|
US6569865B2
(en)
|
2001-06-01 |
2003-05-27 |
Astrazeneca Ab |
Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
|
|
AR036040A1
(es)
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
|
|
WO2003011837A1
(en)
|
2001-08-01 |
2003-02-13 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2003018585A1
(en)
|
2001-08-24 |
2003-03-06 |
Pharmacia & Upjohn Company |
Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
|
|
BR0212123A
(pt)
|
2001-08-24 |
2004-07-20 |
Upjohn Co |
7-aza[2.2.1]biciclo-heptanos substituìdos com arila para o tratamento de doenças
|
|
EP1425286B1
(en)
|
2001-09-12 |
2007-02-28 |
Pharmacia & Upjohn Company LLC |
Substituted 7-aza-[2.2.1]bicycloheptanes for the treatment of diseases
|
|
US6858613B2
(en)
|
2002-02-19 |
2005-02-22 |
Pfizer Inc. |
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
|
|
WO2003072578A1
(en)
|
2002-02-20 |
2003-09-04 |
Pharmacia & Upjohn Company |
Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
|
|
ATE484508T1
(de)
|
2002-04-18 |
2010-10-15 |
Astrazeneca Ab |
Furylverbindungen
|
|
US7417050B2
(en)
|
2002-04-18 |
2008-08-26 |
Astrazeneca Ab |
Heterocyclic compounds
|
|
NZ535978A
(en)
|
2002-04-18 |
2007-10-26 |
Astrazeneca Ab |
Novel spiroazabicyclic heterocyclic amines useful as nicotinic acetylcholine receptor agonists
|
|
US7176198B2
(en)
|
2002-08-01 |
2007-02-13 |
Pfizer Inc. |
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
|
|
SE0202465D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New compounds
|
|
SE0202430D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New Compounds
|
|
MXPA05001702A
(es)
|
2002-08-14 |
2005-04-19 |
Neurosearch As |
Derivados de quinuclidina novedosos y su uso.
|
|
WO2004019943A1
(en)
|
2002-08-30 |
2004-03-11 |
Memory Pharmaceuticals Corporation |
Anabaseine derivatives useful in the treatment of neurodegenerative diseases
|
|
AU2003276919B2
(en)
|
2002-09-25 |
2013-05-16 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
|
CA2503786A1
(en)
|
2002-11-01 |
2004-05-13 |
Pharmacia & Upjohn Company Llc |
Compounds having both alpha7 nicotinic agonist activity and 5ht, antagonist activity for treatment of cns diseases
|
|
WO2004039366A1
(en)
|
2002-11-01 |
2004-05-13 |
Pharmacia & Upjohn Company Llc |
Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy
|
|
ES2462545T3
(es)
|
2002-12-06 |
2014-05-23 |
The Feinstein Institute For Medical Research |
Un procedimiento para la determinación de un agonista colinérgico selectivo para un receptor alfa7 nicotínico
|
|
CN1735441A
(zh)
|
2002-12-11 |
2006-02-15 |
法玛西亚普强责任有限公司 |
治疗注意缺陷多动症的组合
|
|
WO2004052348A2
(en)
|
2002-12-11 |
2004-06-24 |
Pharmacia & Upjohn Company Llc |
Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds
|
|
US6917746B2
(en)
|
2002-12-17 |
2005-07-12 |
3M Innovative Properties Company |
Apparatus and method for creating a fiber optic circuit
|
|
US6777617B2
(en)
|
2002-12-30 |
2004-08-17 |
3M Innovative Properties Company |
Telecommunications terminal
|
|
EP1599476B1
(en)
|
2003-02-27 |
2009-10-14 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives
|
|
BRPI0412382A
(pt)
|
2003-07-08 |
2006-09-19 |
Astrazeneca Ab |
composto , método para a verificação de novos compostos medicinais que se ligam a e modulam a atividade, por agonismo , agonismo parcial, ou antagonismo, do receptor de acetilcolina nicotìnico alfa7, método de tratamento ou profilaxia de uma doença ou condição humana, método para tratamento de jetlag, induzindo interrupção de fumar, vìcio em nicotina, abstinência, dor, e para colite ulcerativa, composição farmacêutica, e, método de tratamento ou prevenção de uma condição ou distúrbio que surge da disfunção de neurotransmissão do receptor de acetilcolina nicotìnico em um mamìfero, e, uso de um composto
|
|
CN1856497A
(zh)
|
2003-09-25 |
2006-11-01 |
阿斯利康(瑞典)有限公司 |
配体
|
|
BRPI0415546A
(pt)
|
2003-10-21 |
2006-12-26 |
Astrazeneca Ab |
composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios
|
|
US20050137398A1
(en)
|
2003-12-22 |
2005-06-23 |
Jianguo Ji |
3-Quinuclidinyl heteroatom bridged biaryl derivatives
|
|
US20050245531A1
(en)
|
2003-12-22 |
2005-11-03 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
|
US20050137217A1
(en)
|
2003-12-22 |
2005-06-23 |
Jianguo Ji |
Spirocyclic quinuclidinic ether derivatives
|
|
US7160876B2
(en)
*
|
2003-12-22 |
2007-01-09 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
|
US20050137203A1
(en)
|
2003-12-22 |
2005-06-23 |
Jianguo Ji |
3-quinuclidinyl amino-substituted biaryl derivatives
|
|
CA2555311A1
(en)
*
|
2004-02-04 |
2005-08-18 |
Neurosearch A/S |
Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
|
|
JP2007534692A
(ja)
|
2004-04-22 |
2007-11-29 |
メモリー・ファーマシューティカルズ・コーポレイション |
インドール、１ｈ−インダゾール、１，２−ベンズイソキサゾール、１，２−ベンゾイソチアゾール、ならびにその調製および使用
|
|
JP2007538011A
(ja)
|
2004-05-07 |
2007-12-27 |
メモリー・ファーマシューティカルズ・コーポレイション |
１ｈ−インダゾール、ベンゾチアゾール、１，２−ベンゾイソキサゾール、１，２−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用
|
|
CA2584838A1
(en)
*
|
2004-10-20 |
2006-05-04 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives and their medical use
|
|
EP1831231A1
(en)
|
2004-12-15 |
2007-09-12 |
AstraZeneca AB |
Nicotinic acetylcholine receptor ligands
|
|
BRPI0517494A
(pt)
*
|
2004-12-22 |
2008-10-14 |
Memory Pharm Corp |
composto, composição farmacêutica, método de ativação/estimulação seletiva de receptores nicotìnicos de a-7 em um paciente em que tal ativação/estimulação tem um efeito terapêutico, método de tratamento de um paciente que sofre de uma doença psicótica, uma doença neurodegenerativa que envolve uma disfunção do sistema colinérgico, e/ou uma condição de debilitação da memória e/ou da cognição, método de tratamento de um paciente que sofre de demência e/ou uma outra condição com perda da memória, método de tratamento de um paciente que sofre de debilitação da memória devido à debilitação cognitiva suave devido ao envelhecimento, mal de alzheimer, esquizofrenia, mal de parkinson, mal de huntington, mal de pick, mal de creutzfeldt-jakob, depressão, envelhecimento, trauma na cabeça, acidente vascular cerebral, hipoxia do snc, senilidade cerebral, demência de multiinfarto, hiv e/ou doença cardiovascular, método de tratamento e/ou prevenção da demência em um paciente com o mal de alzheimer, método de tratamento de um paciente para cortar o vìcio do álcool ou o tratamento de um paciente com a terapia anti-intoxicação, método de tratamento de um paciente para propiciar neuroproteção contra os danos associados com acidentes vasculares cerebrais e isquemia e excitotoxicidade induzida por glutamatos, método de tratamento de um paciente que sofre do vìcio da nicotina, dor, tontura do fuso horário, obesidade e/ou diabetes, método de indução do ato de parar fumar em um paciente, método de tratamento de um paciente que sofre de debilitação cognitiva suave (mci), demência vascular (vad), declìnio cognitivo associado com a idade (aacd), amnésia associada com a cirurgia com o coração aberto, parada cardìaca, anestesia geral, deficiências da memória devido à exposição a agentes anestésicos, debilitação cognitiva induzida pela privação do sono, sìndrome de fadiga crÈnica, narcolepsia, demência relacionada com a aids, debilitação cognitiva relacionada com a epilepsia, sìndrome de down, demência relacionada ao alcoolismo, debilitações da memória induzidas por drogas/substáncias, demência pugilìstica (sìndrome do boxeador), ou demência animal, método para o tratamento da perda da memória, método para o tratamento de um paciente que sofre de debilitação da memória, método para o tratamento ou a profilaxia de uma doença ou de uma condição resultante da disfunção da transmissão do receptor nicotìnico de acetilcolina em um paciente, método para o tratamento ou a profilaxia de uma doença ou de uma condição resultante de receptores nicotìnicos de acetilcolina defeituosos ou funcionando mal em um paciente, método para o tratamento ou a profilaxia de uma doença ou de uma condição resultante da transmissão suprimida do receptor nicotìnico de acetilcolina em um paciente, método para o tratamento ou a profilaxia de uma doença ou de uma condição resultante da perda de sinapses colinérgicas em um paciente, método para a proteção dos neurÈnios em um paciente com neurotoxicidade induzi
|
|
CA2610795C
(en)
|
2005-06-07 |
2015-01-06 |
University Of Florida Research Foundation, Inc. |
3-arylidene-anabaseine compounds as alpha 7 nicotitnic receptor selective ligands
|
|
CA2618700A1
(en)
*
|
2005-08-22 |
2007-03-01 |
Targacept, Inc. |
Heteroaryl-substituted diazatricycloalkanes, methods for its preparation and use thereof
|
|
KR20080048550A
(ko)
|
2005-09-23 |
2008-06-02 |
메모리 파마슈티칼스 코포레이션 |
인다졸, 벤조티아졸, 벤조이소티아졸, 벤즈이속사졸,피라졸로피리딘, 이소티아졸로피리딘, 및 이들의 제법 및용도
|
|
US8316104B2
(en)
*
|
2005-11-15 |
2012-11-20 |
California Institute Of Technology |
Method and apparatus for collaborative system
|
|
SA08290475B1
(ar)
*
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
EP2254598B1
(en)
*
|
2008-02-13 |
2013-07-10 |
Targacept, Inc. |
Combination of alpha 7 nicotinic agonists and antipsychotics
|